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Megalin C-terminal fragmentThe low-density-lipoprotein receptor megalin (LRP2, gp330) is strongly expressed in the kidney, where it is
responsible for the resorption of metabolites from primary urine. One of the main ligands is the complex of
retinol and retinol binding protein. Megalin has been hypothesized to be part of the retinol storage system
in liver. Considering the role of hepatic stellate cells in retinol storage and ﬁbrogenesis we investigated
mouse strains that developed different degrees of ﬁbrosis after challenge with CCl4. Immunoblotting revealed
the invariable expression of themegalin C-terminal fragment independent of liver damage in all strains. How-
ever, only a speciﬁc cell population in centrilobular areas of ﬁbrotic livers from DBA/2J mice, which were most
susceptible for CCl4-induced ﬁbrogenesis in our study, was stained using megalin-speciﬁc antibodies. Double
immunostaining indicated that a subset of hepatic macrophages might represent themegalin-expressing cells
in ﬁbrotic liver. Fluorescence activated cell sorting based isolation of hepatic macrophages andmegalin specif-
ic expression analysis demonstrated the transcription of the whole megalin gene in liver macrophages. We
argue that megalin might exhibit a proinﬂammatory effect by the uptake of retinoids in recruited monocytes,
which thereby differentiate to liver macrophages and potentiate ﬁbrogenesis by the release of proinﬂamma-
tory mediators. Otherwise, megalin might be activated in macrophages during advanced ﬁbrogenesis and act
as a negative regulator of proinﬂammatory genes.edicine I, University Hospital
l.: +49 228 15213; fax: +49
e (U. Pieper-Fürst).
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Progressive liver ﬁbrosis is the ﬁnal stage of all chronic liver dis-
eases. It is characterized by the increase of extracellular matrix
(ECM) and the alteration of its composition [1]. As a consequence,
the structure and function of the liver are disrupted, ﬁnally resulting
in liver cirrhosis. Hepatic stellate cells (HSC) are considered as the
main source of ECM during liver ﬁbrogenesis [2]. In healthy liver,
HSC are localized in the space of Disse, and they represent the main
storage site for vitamin A (retinol) in the body. During ﬁbrosis, HSC
are activated by oxidative stress and proinﬂammatory cytokines to a
myoﬁbroblast-like cell type and lose their ability to store vitamin A.
Instead, they produce large amounts of α-smooth muscle actin and
ECM components including collagen (type I, III, IV), proteoglycans,
and ﬁbronectin. In addition, HSC overexpress tissue inhibitors ofmatrix metalloproteinases, which inhibit ECM degradation [3]. Be-
sides the sinusoidal endothelium and hepatocytes, the resident tissue
macrophages of the liver (Kupffer cells) contribute to HSC activation
by the secretion of cytokines, nitric oxide, reactive oxygen species,
and other mediators [4]. Liver macrophages largely originate from
the bone marrow and are constantly recruited from blood monocytes.
Recently, more precise investigations revealed that Gr1hi monocytes
accumulate in the liver during carbon tetrachloride (CCl4)-induced
liver injury that results in an up to 10-fold increase in CD11b+
F4/80+ intrahepatic macrophages [5].
The progression of liver ﬁbrosis depends not only on age and en-
vironmental factors but also on genetic variants and, therefore, varies
between different individuals. Quantitative trait locus analysis (QTL
analysis) [6] in mice is an important tool for the identiﬁcation of
genes that could be responsible for the variability in the progression
of liver ﬁbrosis. Recently, the hepatic ﬁbrogenic gene 1 (Hﬁb 1) and
the Hc gene encoding complement factor C5 were identiﬁed by QTL
analysis [7,8]. An important tool for QTL analysis are BXD mouse
lines that were generated from the two inbred mouse strains
DBA/2J and C57BL/6J [9]. These two strains were crossed and the
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Fig. 1. Schematic description of ectodomain shedding and RIP of megalin according to
Biemesderfer [16]. Matrixmetalloprotease (MMP) activity that is regulated by protein
kinase C (PKC) and the binding of ligands to the N-terminal extracellular part of mega-
lin results in the shedding of its ectodomain. The arising megalin C-terminal fragment
(MCTF) is cleaved by γ-secretase activity within the membrane and the resulting cyto-
plasmic tail is released into the cytoplasm. It is presumed that the cytoplasmic tail func-
tions as a transcriptional regulator in the nucleus.
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to obtain inbred BXD lines, which show a unique mosaic genome of
their two founder strains. Since strains DBA/2J and C57BL/6J display
high and low susceptibility for CCl4-induced ﬁbrosis, respectively,
BXD lines exhibit genetically based differences in the progression of
liver ﬁbrosis.
The endocytotic multiligand receptor megalin (LRP2, gp330) is a
glycoprotein with a molecular weight of about 600 kDa (517 kD in
the non-glycosylated form) [10]. Megalin was detected mainly in kid-
ney [11], but also in the lung, male and female reproductive system,
thyroid and parathyroid, ependyma, eye, small intestine, and gall-
bladder [12–14] as well as in the yolk sac and neural tube [15]. In kid-
ney, megalin is localized in the apical membrane of proximal tubular
cells, where it is responsible for the resorption of metabolites from
primary urine. The receptor mediates the endocytotic uptake of sev-
eral ligands including vitamin-binding proteins, lipoproteins, hor-
mones, and enzymes [16]. Interestingly, one of the main ligands of
megalin is the complex of retinol and retinol binding protein (reti-
nol-RBP).
Megalin is a member of the low-density-lipoprotein receptor
(LDLR)-family [17]. All proteins of this family exhibit structural simi-
larities. In detail, they are composed of an extracellular domain, a
transmembrane domain, and a cytoplasmic tail. The extracellular do-
main (4400 amino acids [aa]) of rat megalin contains four clusters of
cysteine-rich complement-type repeats, which constitute the ligand-
binding regions. They are separated and followed by 17 epidermal
growth factor-type repeats and eight cysteine-poor spacer regions
containing YWTD consensus sequences, which are responsible for
the pH-dependent release of ligands in the endosomal compartment
[10,18]. In rat, the single transmembrane and the cytoplasmic domain
comprise 22 aa and 213 aa, respectively [10]. The cytoplasmic domain
shows very low similarities between the members of the LDLR-family
with the exception of the NPxY sequences. Megalin contains three of
these motifs. The ﬁrst and third NPxY motifs are required for efﬁcient
endocytosis [19], and the second NPxY motif is responsible for the
apical sorting of megalin [20].
Recently, it was shown that the receptor function of megalin could
be linked to transcriptional regulation by regulated intramembrane
proteolysis (RIP) (Fig. 1) [21,22]. RIP is an evolutionary conserved
process that has been analyzed during investigation of the low densi-
ty lipoprotein receptor-related protein (LRP) [23], the Notch protein
in Drosophila melanogaster [24], and the amyloid precursor protein
(APP) [25]. Biemesderfer and co-workers [21] have demonstrated
that megalin is processed by protein kinase C and/or ligand binding
regulated metalloprotease-mediated ectodomain shedding, and the
resulting membrane-associated megalin C-terminal fragment is the
substrate of γ-secretase (Fig. 1). First evidence for the involvement
of the presumably resulting cytoplasmic tail in signal transduction
was provided by Oleinikov et al. [26], demonstrating that the Disabled
protein 2 (Dab2), a mammalian structural analog of Drosophila Dis-
abled, binds to the third NPxYmotif of the cytoplasmic tail of megalin.
Additionally, the megalin-binding protein (MegBP) was identiﬁed to
bind to the cytoplasmic tail of megalin; MegBP in turn interacts
with transcriptional regulators or components of signal transduction
cascades [27].
Since retinol-RBP binds to its receptor megalin in kidney and be-
cause of the role of HSC in retinol storage, we hypothesized that
megalin might be part of the retinol storage system in liver. Although
the loss of lipid droplets is considered as main feature of HSC during
ﬁbrogenesis, the signiﬁcance of this absence of retinoids in liver ﬁbro-
genesis was never elucidated. Recently, it was demonstrated that the
lack of retinoid-containing lipid droplets in lecithin-retinol acyltrans-
ferase-deﬁcient mice does not promote HSC activation and ﬁbrogen-
esis [28]. Nevertheless, the activation of HSC and the loss of their
retinol storage ability in ﬁbrotic liver represent an applicable model
to demonstrate the expected differences in the expression of megalinduring hepatic ﬁbrogenesis. Therefore, we investigated the hepatic
expression of megalin in both, healthy and ﬁbrotic murine livers.
2. Materials und methods
2.1. Inbred mouse strains
DBA/2J, C57BL/6J and two BXD recombinant inbred mouse lines
(BXD51 and BXD61), which have been generated by inbreeding F2
progeny from C57BL/6J and DBA/2J mouse strains, were received
from Jackson Laboratory (DBA/2J, C57BL/6J) or from Oak Ridge Labo-
ratory (BXD51, BXD61), and were bred in the facility of the Neuro-
Bsik consortium from the VU University Amsterdam.
2.2. Phenotypic characterization of liver ﬁbrosis
Liver ﬁbrosis was induced by challenging 6- to 8-weeks old mice
twice weekly with CCl4 (i.e. a total of 12 i.p. injections applying
0.7 mg/kg body weight) [7]. We obtained organs and blood samples
48 h after the last injection. Blood was collected from the vena cava
inferior and centrifuged at 4 °C for 20 min and 2000×g. Serum was
stored at −80 °C. Serum activity of alanine aminotransferase (ALT)
was determined according to the IFCC reference method [29]. Quanti-
ﬁcation of hepatic collagen was performed via colorimetric measure-
ment of the collagen-speciﬁc amino acid hydroxyproline at 558 nm
after acid hydrolysis of liver homogenate [30]. To assess hepatic colla-
gen deposition by histopathology, Sirius red staining was performed
according to standard procedures [7].
All experiments were done in compliance with the relevant laws
and institutional guidelines and were approved by the Animal Care
and Use Committee of the District of Cologne (Germany).
2.3. Cloning and expression of a plasmid representing the cytoplasmic tail
of megalin
RNA was isolated from murine kidney using the RNeasy kit (Qia-
gen) and reverse transcribed into cDNA using oligo dT-primers and
SuperScript II reverse transcriptase (Invitrogen). Standard PCR was
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TCC CTT TTA CCC TCT CTG CCC-′3), containing an MluI restriction
site, and the reverse primer Ex4 (5′-TTT GTC GAC TAC ATC AGA GTC
TTC CTT CAC AAG GTT TGC-3′), containing a SalI restriction site, to
amplify speciﬁc DNA representing the cytoplasmic tail of megalin.
The PCR product was digested with MluI and SalI and cloned into
the vector pET23aT7 [31]. The resulting plasmid pETW2-8 contained
627 bp from position 13,526 to 14,152 of the murine megalin tran-
script (Ensembl transcript ID ENSMUST00000080953) for expression
as His-tagged fusion protein. Plasmid pETW2-8 was transformed into
E. coli BL21 codon plus (DE3)-RP (Stratagene), and expression of the
fusion protein was induced by addition of isopropyl-β-D-thiogalacto-
pyranosid (IPTG) to the culture medium. Puriﬁcation of the fusion
protein was performed using the Ni-NTA kit (Qiagen).
2.4. Generation of antibodies
The expressed and puriﬁed cytoplasmic tail of megalin was used
to immunize a rabbit. This immunization was performed by BioGenes
(Berlin, Germany). Speciﬁc anti-megalin antibodies were recovered
by afﬁnity binding to the protein [32]. For this purpose, the cytoplas-
mic tail of megalin was separated on a 12% (w/v) SDS-polyacrylamide
gel [33] and blotted onto a PVDF membrane (Pall). The part of the
membrane containing the megalin band was cut out, and free binding
sites were blocked with 5% (w/v) non-fat milk powder in PBS con-
taining 0.1% (v/v) Tween 20 (PBS-Tween) over night at 4 °C. After
washing with PBS-Tween, anti-megalin antiserum was added to the
membrane stripe and incubated 2 h at room temperature (RT). Sub-
sequently, the membrane was washed three times with PBS-Tween.
Speciﬁc anti-megalin antibodies were eluted with 5 mM glycine/HCl,
pH 2.3, 0.5 M NaCl, 0.5% (v/v) Tween 20 and 100 μg/ml bovine serum
albumin (BSA) during 30 s at RT. The eluted antibodies were neutral-
ized with 50 mM Na2HPO4 and stored at −20 °C.
2.5. SDS-PAGE and immunoblotting
Frozen liver and kidney samples were homogenized in 25 mM
Tris, 5 mM EDTA, pH 7.0, containing complete EDTA-free protease in-
hibitor (Roche). The homogenates were spiked with SDS sample buff-
er and separated on a 3–15% (w/v) polyacrylamide gradient gel under
reducing conditions according to Laemmli [33]. For immunoblotting,
the proteins were transferred to a PVDF membrane (Pall) in a tank
blot over night at a constant voltage of 40 V and 4 °C. Subsequently,
free binding sites of the membrane were blocked with 5% (w/v)
non-fat milk powder in PBS-Tween for 2 h at RT. Thereafter, the
membrane was incubated with anti-megalin antibodies (diluted
1:2000 in 2.5% (w/v) non-fat milk powder in PBS-Tween) over
night at 4 °C. After washing four times in PBS-Tween, the membrane
was incubated with goat anti-rabbit peroxidase conjugate (Calbio-
chem) (diluted 1:4000 in 2.5% (w/v) non-fat milk powder in PBS-
Tween) for 20 min at RT. After washing (four times in PBS-Tween),
speciﬁcally bound anti-megalin antibodies were visualized using Ace-
Glow ultrasensitive chemiluminescence substrate (Peqlab). Control
staining was performed using anti-β-actin antibody (Sigma).
2.6. Immunohistochemistry and immunoﬂuorescence staining
Formalin-ﬁxed and parafﬁn-embedded tissue sections of about
3 μm thickness were deparafﬁnized and rehydrated. Subsequently,
the sections were boiled in 10 mM citrate buffer, pH 6.0, for 15 min
in a microwave oven for antigen retrieval. Endogenous peroxidase
was blocked by incubation of the sections in 3% (v/v) H2O2 in PBS.
After blocking with an avidin and biotin blocking system (Dako)
and washing in PBS, the sections were incubated with the primary an-
tibody anti-megalin (1:200 diluted in 3% (w/v) bovine serum albumin
in PBS-Tween) over night at 4 °C. Speciﬁc binding of primaryantibodies was revealed with biotinylated goat anti-rabbit antibody,
streptavidin peroxidase conjugate and 3-amino-9-ethylcarbazole
(AEC) staining using the NOVADetect detection system (Dianova). Fi-
nally, nuclei were stained with Mayer's hematoxylin (Dako).
For double-labeling experiments, a combination of immunohisto-
chemistry and immunoﬂuorescence staining was applied. The sec-
tions were pre-treated as described above and additionally
incubated in 0.1% (w/v) Sudan black in 70% (v/v) ethanol for 20 min
at RT to reduce the autoﬂuorescence of liver tissue. After washing
with PBS, a mixture of two primary antibodies (anti-megalin 1:50 to
1:100, anti-F4/80 [BMA Biomedicals] 1:100 or anti-αSMA [Sigma]
1:200 diluted in 3% (w/v) bovine serum albumin in PBS-Tween)
was added and incubated over night at 4 °C. Speciﬁc binding of anti-
megalin antibodies was demonstrated either using the NOVADetect
detection system or using ﬂuorescent DyLight 649-conjugated goat
anti-rabbit antibody (1:100, Jackson ImmunoResearch). Speciﬁc
binding of anti-F4/80 antibody was demonstrated using a biotiny-
lated goat anti-rat antibody (1:500, Dianova) and the NOVADetect
detection system. For immunoﬂuorescence staining of speciﬁc
bound anti-αSMA antibody, Cy5-conjugated goat anti-mouse anti-
body (1:100, Jackson ImmunoResearch) was applied. Secondary anti-
bodies were diluted in 3% (w/v) bovine serum albumin in PBS-Tween
and added simultaneously for 3 h at RT. Following AEC staining, the
sections were embedded in Immunoselect Antifading Mounting Me-
dium (Dianova) containing DAPI.
2.7. Isolation and analysis of liver macrophages and HSC
Livers from CCl4-challenged DBA/2J (3 mice), CCl4-challenged
C57BL/6J (2 mice) and control mice (3 mice each) were used to iso-
late macrophages and HSC as described previously [5,34]. Brieﬂy,
livers were digested by collagenase, and single cell suspensions
were enriched for leukocytes by gradient centrifugation. Following
staining with speciﬁc antibodies, HSC were identiﬁed as live UV-auto-
ﬂuorescent+CD45− CD11b− F4/80− Ly6G− cells and macrophages
as live UV-auto-ﬂuorescent-CD45+ Ly6G− CD11b+ F4/80+ cells.
FACS-based sorting was performed on a BD Aria II with purities N95%.
2.8. Real-time gene expression analysis
Isolated liver macrophages and HSC were resuspended in RNA-
pure (Peqlab), and total RNA was isolated. Complementary DNA
(cDNA) was generated using RNA and the ImProm-II reverse tran-
scription system (Promega). Real-time PCR (TaqMan) was performed
using the gene expression assays Mm01328171_m_1 derived from
the C-terminal part of the megalin gene and Mm01327961_m1 (Ap-
plied Biosystems) derived from the ectodomain coding region of the
megalin gene. The values were normalized to 18S ribosomal RNA.
2.9. Statistics
All data were expressed as mean±standard error (SE). Analysis of
variance (ANOVA) with post-hoc Bonferroni correction was applied
to compare means between groups. Two-sided Pb0.05 was consid-
ered signiﬁcant.
3. Results
3.1. Demonstration of different susceptibility of ﬁbrosis in the mouse
strains BXD51, BXD61, C57BL/6J and DBA/2J
Since we assumed that megalin is part of the vitamin A storage
system in liver and that its expression changes during ﬁbrogenesis,
we investigated mouse strains with different susceptibility to hepatic
ﬁbrosis [8]. In particular, we employed DBA/2J, C57BL/6J and the two
BXD recombinant inbred mouse lines BXD51 and BXD61. BXD lines
1643U. Pieper-Fürst et al. / Biochimica et Biophysica Acta 1812 (2011) 1640–1648show a unique mosaic gene set of their two founder strains DBA/2J
and C57BL/6J and have been used for quantitative trait locus (QTL)-
analysis of proﬁbrogenic susceptibility genes (R. Hall et al., unpub-
lished observations).
Experimental liver ﬁbrosis was induced by challenging the mice
twice weekly with CCl4 for 6 weeks, and hydroxyproline concentra-
tions in liver were determined to quantify hepatic collagen contents.
Panel A of Fig. 2 illustrates that in livers of unchallenged mice, the hy-
droxyproline contents were relatively low (BXD51, 254±34 μg/g
liver, BXD61, 284±35 μg/g liver, C57BL/6J, 211±13 μg/g liver and
DBA/2J, 148±11 μg/g liver). In CCl4-challenged livers of strains
BXD51, BXD61 and C57BL/6J, we measured 441±26, 372±25 and
392±32 μg hydroxyproline/g liver, respectively (Pb0.05 compared
to unchallenged mice, except BXD61). The highest hydroxyproline
content was measured in CCl4-challenged DBA/2J mice (568±
30 μg/g liver; Pb0.01 compared with CCl4-challenged mice of the
other strains) (Fig. 2A). These ﬁndings were also reﬂected in Sirius
red staining. In liver sections of CCl4-challenged DBA/2J mice, we
found intense bridging ﬁbrosis from central vein to central vein
(Fig. 3B), whereas in liver sections of CCl4-challenged BXD (Fig. 3C)
or C57BL/6J mice, the bridging ﬁbrosis was rather mild. No such stain-
ing was observed in unchallenged mice (Fig. 3A).
In line with these ﬁndings, the activity of ALT as indicator for ne-
crosis of liver parenchyma increased upon CCl4-challenge (427±
91 U/l, 431±86 U/l and 359±112 U/l in strains BXD51, BXD61 andA
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Fig. 2. Hydroxyproline contents of liver homogenates and ALT activities in serum of
BXD, C57BL/6J and DBA/2J mice. Mice were challenged twice weekly with CCl4 over a
period of 6 weeks. Data are expressed as the mean±SE per group. (A) Measurement
of hydroxyproline contents in liver homogenates of challenged and unchallenged
□ mice. Data are derived from 5 to 20 independent experiments. * Pb0.01 compared
to CCl4-challenged mice of the other strains. (B) Determination of ALT activities in
serum of challenged and unchallenged □ mice (N=3–19). * Pb0.05 compared to
CCl4-challenged mice of the other strains.C57BL/6J, respectively) (Fig. 2B). The highest activity was measured
in serum of DBA/2J mice (854±168 U/l; Pb0.05 compared with
CCl4-challenged mice of the other strains). The activity in serum of
control mice was signiﬁcantly lower (34±2 U/l, 25±2 U/l, 34±
2 U/l and 26±4 U/l in serum of strains BXD51, BXD61, C57BL/6J and
DBA/2J, respectively; Pb0.05 compared with CCl4-challenged mice
of each strain). Overall, the results revealed a variable degree of he-
patic ﬁbrosis in the four mouse strains BXD51, BXD61, C57BL/6J,
and DBA/2J.
3.2. Cloning and expression of the megalin cytoplasmic tail
In order to study megalin expression at the protein level, we
intended to generate an antibody against the cytoplasmic tail of
megalin. Therefore, a sequence of 627 bp of the gene transcript
encoding the cytoplasmic tail of megalin was cloned into vector
pET23aT7, yielding the plasmid pETW2-8 that was transformed into
E. coli BL21 codon plus (DE3)-RP. The cytoplasmic tail of megalin
was expressed as a His-tagged fusion protein and puriﬁed by afﬁnity
chromatography. The molecular mass of the fusion protein was calcu-
lated to be about 26,000. SDS-PAGE revealed a band of a molecular
mass of about 30,000 (Fig. 4, lane 10). However, mass spectrometry
of this protein band (Sebastian Franken, Institute of Biochemistry
and Molecular Biology, University of Bonn) pointed out that it was
consistent with the His-tagged megalin cytoplasmic fragment (data
not shown).
3.3. Detection of the megalin C-terminal fragment (MCTF) in liver
homogenates
The His-tagged fusion protein containing the cytoplasmic tail of
megalin was used to immunize a rabbit. Since the fusion protein frac-
tion eluted from the Ni-afﬁnity column contained a minor contamina-
tion of Heat shock protein 70 from E. coli as revealed by mass
spectrometry (Sebastian Franken, Institute of Biochemistry and Mo-
lecular Biology, University of Bonn) (data not shown), the polyclonal
antiserum included also anti-heat shock protein antibodies. There-
fore, speciﬁc megalin antibodies were recovered by afﬁnity binding
to the blotted C-terminal fragment of megalin. The resulting speciﬁc
anti-megalin antibodies were employed to investigate the expression
of megalin in livers of BXD, C57BL/6J and DBA/2J mice. Hence, tissue
homogenates were separated on 3–15% SDS-polyacrylamide gradient
gels and blotted onto PVDF-membranes. Immunoblotting with
megalin-speciﬁc antibodies revealed reactivity with both a high and
a low molecular mass band in control experiments using kidney sam-
ples (Fig. 4, lane 1). The high molecular mass band of more than
500 kD presumably represents the whole transmembrane protein
megalin consisting of the ectodomain, the transmembrane domain,
and the cytoplasmic tail. The low molecular mass band of about 30
to 35 kD (Fig. 4, lane 1) runs slightly higher than the molecular
mass band representing the cytoplasmic tail that was expressed in
E. coli (Fig. 4, lane 10). Therefore, we assumed that the 30 to 35 kD
band represents the megalin C-terminal fragment (MCTF), which is
a result of ectodomain shedding. The MCTF contains additionally 22
amino acids of the transmembrane domain as well as probably fur-
ther amino acids of the extracellular region of megalin and should
have a slightly higher molecular mass than the cytoplasmic tail.
These ﬁndings are in accordance with the results of Zou and co-
workers [21], who demonstrated also reactivity with two proteins
after immunoblotting using antibodies against the cytoplasmic tail
of megalin and rat renal microsomes as well as an opossum kidney
proximal tubule cell line.
In experiments using liver homogenates and anti-megalin anti-
bodies, only the low molecular mass band of MCTF was detected
(Fig. 4, lanes 2 to 9 and 11 to 14). Interestingly, there was no evidence
for the expression of whole megalin in liver. In contrast to our initial
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Fig. 3. Staining of ﬁbrotic areas and immunolocalization of MCTF in liver. Parafﬁn sections of livers from unchallenged DBA/2J (A), CCl4-challenged DBA/2J (B) and CCl4-challenged
BXD61 (C) were stained with Sirius red to visualize the degree of ﬁbrosis in the different mouse strains. Panel (D) represents a serial section of panel (B). Panel (D) and the insets
(E), (F) and (G) display the localization of MCTF in centrilobular zones of ﬁbrotic liver. Speciﬁcally bound antibodies were detected with a biotinylated second antibody, peroxidase-
conjugate and a chromogen substrate. (H), speciﬁc control staining of megalin in proximal tubules of murine kidney.
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liver homogenates from CCl4-challenged BXD51, BXD61, C57BL/6J
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Fig. 4. Immunostaining of MCTF in liver homogenates. In total, 200 μg protein from liver hom
(w/v) SDS-polyacrylamide gradient gels (A, B). Megalin or MCTF were detected by immuno
antibodies and a chemiluminescence substrate. 1, Balb/c kidney control; 2, Balb/c liver contr
CCl4-challenged DBA/2J mice; 7, liver homogenate from unchallenged BXD51 mouse; 8, 9
recombinantly expressed cytoplasmic tail (CT); 11/12, liver homogenates from C57BL
MCTF, megalin C-terminal fragment.13/14, 5/6, respectively), nor between liver homogenates from
unchallenged or CCl4-challenged BXD51, C57BL/6J and DBA/2J mice
(Fig. 4, lanes 7, 11/12, 3/4 and 9, 13/14, 5/6, respectively). Hence,CT
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ogenates or 100 μg from a kidney homogenate, respectively, were separated on 3–15%
blotting using megalin-speciﬁc antibodies, horseradish peroxidase-conjugated second
ol; 3, 4, liver homogenate from unchallenged DBA/2J mice; 5, 6, liver homogenates from
, liver homogenates from CCl4-challenged BXD61 and BXD51 mice, respectively; 10,
/6J control mice; 13/14, liver homogenates from CCl4-challenged C57BL/6J mice.
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to the degree of ﬁbrosis in liver.
Since there were marked differences between the expression of
megalin in kidney and liver, we designed experiments to further
demonstrate the speciﬁcity of the anti-megalin antibody by blocking
experiments. The anti-megalin antibodies were incubated with the
5-fold or 7.5-fold amount of recombinantly expressed cytoplasmic
tail of megalin, respectively, prior to the addition to liver homoge-
nates (Fig. 5A). The immunoblot clearly revealed the blocking of the
antibody reaction by a 7.5-fold excess of immunogen (Fig. 5A, lane 3).
3.4. Identiﬁcation of macrophages as the MCTF-expressing cell
population in centrilobular areas of the ﬁbrotic liver
In order to analyze the localization of MCTF-positive cells in liver,
we performed immunostaining of liver sections. Anti-megalin anti-
bodies revealed reactivity with a speciﬁc cell population in centrilob-
ular areas of liver from DBA/2J mice challenged with CCl4 (Fig. 3D–G).
Blocking of the antibody reaction by an incubation of the anti-megalin
antibody with a 7-fold amount of immunogen prior to the addition to
the liver sections demonstrates the speciﬁcity of the staining proce-
dure (Fig. 5B). Surprisingly, we did not detect staining of cells in ﬁ-
brotic livers of BXD and C57BL/6J mice or in livers of unchallenged
mice, even though immunoblotting showed reactivity with the
MCTF in liver homogenates from these mice. Since we assumed that
the MCTF-expressing cells could represent macrophages rather than
HSC, we performed double-staining of sections of challenged DBA/2J
mice using the anti-megalin antibody and an antibody directed
against the F4/80 glycoprotein, which is expressed on the surface of
residential tissue macrophages like Kupffer cells as well as by inﬁl-
trating monocytes/macrophages in the liver [35]. To visualize the spe-
ciﬁcally bound primary antibodies, we applied both a ﬂuorescent
secondary antibody with an emission peak in the far-red part of the
spectrum and, with the intent to avoid the difﬁculties concerning
the autoﬂuorescence of liver tissue in almost the whole visible part
of the spectrum [36], an immunoenzymatic detection system using
a chromogen substrate. Fluorescence and light microscopy of theMCTF
β-Actin
100 µm
a
+ 5x- CT
1 2
-CT
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B
Fig. 5. Demonstration of the speciﬁcity of the anti-megalin antibody by blocking experimen
dient gel and blotted onto PVDF membrane. Immunoblotting was performed using anti-meg
ously incubated with the 5-fold (lane 2) or 7.5-fold (lane 3) amount of recombinantly expres
(B) Immunohistochemical staining of parafﬁn sections of livers from CCl4-challenged DBA/2
amount of CT for 30 min at RT (b), respectively.same section revealed that identical cells showed reactivity with
both megalin and F4/80-speciﬁc antibodies (Fig. 6A and B). Hence,
this clearly demonstrated that the MCTF-expressing cells represent
macrophages. In contrast, staining of liver sections with anti-
megalin antibody and anti-α smooth muscle actin (αSMA) antibody
revealed no overlap and demonstrated the lack of MCTF in αSMA-
positive non-parenchymal cells such as activated HSC and portal
myoﬁbroblasts (Fig. 7A and B) [37].
3.5. Isolation of liver macrophages by ﬂuorescence activated cell sorting
(FACS) and afﬁrmation of megalin gene expression by real-time PCR
Livers from CCl4-challenged DBA/2J and C57BL/6J as well as appro-
priate unchallenged controlmicewere pooled, respectively, andmacro-
phages and HSC were isolated by FACS (Fig. 8 A). RNA of macrophages
and HSC were gathered and cDNA was generated. Real-time PCR was
performed using both, a gene expression assay derived from the C-
terminal part of themegalin gene and an assay derived from the ectodo-
main coding region of the megalin gene. TaqMan gene expression anal-
ysis unequivocally revealed megalin gene expression in macrophages
using both assays (Fig. 8 B, panels a and b). In contrast, expression of
megalin could not be detected in HSC.
4. Discussion
Our investigations demonstrate the expression of MCTF in all liver
homogenates of healthy and ﬁbrotic BXD, C57BL/6J and DBA/2J mice,
but there was no evidence for the expression of whole megalin in
liver. In vivo, MCTF was only detected in ﬁbrotic areas of liver sections
of DBA/2J mice that were challenged with CCl4 and exhibited a distinct
centrilobular bridging ﬁbrosis. Using liver sections of healthy BXD51,
C57BL/6J and DBA/2J mice as well as mice with mild ﬁbrosis, we could
not detect any staining of cellswith anti-megalin antibodies. These ﬁnd-
ings are apparently contradictory to immunoblot analysis.We speculate
that the lack of reactivity of anti-megalin antibodieswithMCTF in some
liver sections could be the result of masking of antibody binding sites in100 µm
b
 CT + 7.5x CT
3
+ 7x CT
ts. (A) Liver homogenates were separated on a 3–15% (w/v) SDS-polyacrylamide gra-
alin antibodies (lane 1) as well as blocked anti-megalin antibodies, which were previ-
sed cytoplasmic tail of megalin (CT) for 30 min at room temperature (RT), respectively.
J using megalin speciﬁc antibodies (a) or antibodies that were blocked with the 7-fold
AB
i
k
i
k
50 µm
Fig. 6. Double staining of MCTF expressing macrophages in ﬁbrotic liver from DBA/2J
mice. Parafﬁn sections of liver from CCl4-challenged DBA/2J mice were concurrently in-
cubated with anti-megalin and anti-F4/80 antibodies. Bound megalin speciﬁc anti-
bodies were revealed using a DyLight 649-labeled secondary antibody (A), while
bound F4/80-speciﬁc antibodies were visualized using an immunoenzymatic detection
system (B). Identical cells are marked by lower case letters (i, k).
m
n
o
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B
Fig. 7. Double staining of ﬁbrotic liver section from DBA/2J mice with megalin and
αSMA-speciﬁc antibodies. Parafﬁn sections of liver from CCl4-challenged DBA/2J mice
were concurrently incubated with anti-αSMA antibodies and anti-megalin antibodies.
Bound αSMA-speciﬁc antibodies were visualized using a Cy5-labeled secondary anti-
body (A), while bound megalin speciﬁc antibodies were shown using an immunoenzy-
matic detection system (B). Identical cells are marked by lower case letters (m, n, o).
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cytotic process or signaling pathways.
Our in vivo investigations of liver sections clearly demonstrate
the expression of MCTF by a speciﬁc set of macrophages in areas of
the liver with strong ﬁbrosis and not by αSMA-positive non-
parenchymal cells such as activated HSC. These ﬁndings were con-
ﬁrmed by gene expression analysis, which corroborates the tran-
scription of the megalin gene in macrophages using both, an assay
speciﬁc for the C-terminal tail and an assay speciﬁc for the ectodo-
main of megalin.
Based on our results of immunoblotting, which provided only evi-
dence for the expression of MCTF, and the gene expression analysis,
which rather afﬁrmed the transcription of the whole megalin gene,
we assume that the entire megalin gene product is translated but the
ectodomain is totally cleaved. This hypothesis is to some extent sub-
stantiated by the work of Zou and co-workers [21], who detected that
antibodies against the ectodomain or the cytoplasmic tail ofmegalin, re-
spectively, react with different subcellular compartments of kidney
proximal tubules. In detail, both domains were found along coated
pits and dense apical tubules, whereas the ectodomainwas additionally
detected on the microvillar surface of proximal tubular cells [21].
The results of this work rebut the initial hypothesis of the partici-
pation of megalin in the retinol storage system of HSC and disagree
with the ﬁndings of Gressner et al. [38], who reported expression of
megalin by HSC. However, retinol plays an important role inenhancing immunity by affecting both the differentiation of mono-
cytes to macrophages and the function of differentiated macrophages
[39]. Recently, the inﬂuence of vitamin A hypervitaminosis in CCl4-
mediated ﬁbrosis of rat liver was investigated in detail [40]. It was
demonstrated that hypervitaminotic CCl4-challenged animals suf-
fered an increased severity of ﬁbrosis compared with CCl4-exposed
animals receiving a standard diet. The authors argued that vitamin A
might potentiate CCl4-induced liver injury by enhancing the release
of oxygen species from Kupffer cells or other macrophages. Hagen et
al. [41] investigated the uptake of retinol in macrophages and sug-
gested that the low-density lipoprotein (LDL) receptor and LDL-
receptor related protein could be involved in its uptake. Megalin be-
longs to the LDL receptor family and could be part of the retinol uptake
system in dedicatedmacrophages. Themegalin-positive macrophages
in sections of ﬁbrotic DBA/2J mice might represent monocytes that
were recruited from blood [5]. These monocytes might express mega-
lin for the uptake of retinoids, which would affect further differentia-
tion, and promote ﬁbrogenesis by proinﬂammatory mediators. In this
settings, wewould expect an increased level of MCTF in immunoblots,
but we observed a constant expression of MCTF in all liver homoge-
nates from healthy or ﬁbrotic mice. Alternatively, we speculate that
in resident macrophages of DBA/2J, which is the most susceptible
strain for CCl4-induced liver injury, the uptake of retinoids via an “ac-
tivated” megalin (i.e. unmasked megalin, which is detectable by the
anti-megalin antibody in liver sections) is enhanced and, therefore,
the proﬁbrogenic effect of CCl4 is potentiated.
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Fig. 8. FACS-based isolation of HSC and liver macrophages as well as megalin gene expression analysis. (A) Following liver perfusion and collagenase–pronase-digestion, single cells
are enriched for non-parenchymal cells by an 18% gradient of Nycodenz solution. Cells from the interface are stained with antibodies (CD45, Ly6G, CD11b, F4/80) and subjected to
FACS sorting with a BD Aria II instrument that is equipped with a 355 nm-UV laser. Left: Pre-sorting, about 3% of the enriched non-parenchymal cells are HSC (autoﬂuoresence/UV-
positive, CD45 negative) and 40% are leukocytes (CD45-positive, autoﬂuorescence/UV-negative). Middle: HSC are identiﬁed as CD45-negative, Ly6G-CD11b-F4/80-negative, auto-
ﬂuorescence-positive cells at a purity N95%. Right: Macrophages are sorted as autoﬂuorescence-negative, Ly6G-negative, CD45+, CD11b+and F4/80+ cells at a purity N95%. (B)
Liver macrophages were isolated from CCl4-challenged DBA/2J, CCl4-challenged C57BL/6J and unchallenged control mice. RNA was transcribed into cDNA and applied during gene
expression analysis using both, an assay derived from the CT coding region of the gene (a) and an assay derived from the ectodomain coding region of the gene (b). Expression is
shown as the negative normalized cycle number (−ΔCt).
1647U. Pieper-Fürst et al. / Biochimica et Biophysica Acta 1812 (2011) 1640–1648It is questionable whether megalin is only part of a retinoid uptake
system in macrophages and promotes the inﬂammation or whether
megalin directly participates in the regulation of the inﬂammatory re-
sponse. Recently, a nuclear signaling mechanism has been reported
involving the limitation of lipopolysaccharide-induced inﬂammation
by the intracellular domain of the LDL receptor-related protein 1
(LRP1) [42]. According to these results, MCTF might be activated dur-
ing speciﬁc and/or severe types of chronic liver injury and function as
negative regulator of genes that promote inﬂammatory mechanisms
during liver ﬁbrogenesis.
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